Polaris Wealth Advisory Group, LLC Abb Vie Inc. Transaction History
Polaris Wealth Advisory Group, LLC
- $1.3 Billion
- Q3 2023
A detailed history of Polaris Wealth Advisory Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Polaris Wealth Advisory Group, LLC holds 212,188 shares of ABBV stock, worth $40.2 Million. This represents 2.43% of its overall portfolio holdings.
Number of Shares
212,188
Previous 211,651
0.25%
Holding current value
$40.2 Million
Previous $28.5 Million
10.92%
% of portfolio
2.43%
Previous 2.2%
Shares
22 transactions
Others Institutions Holding ABBV
# of Institutions
3,757Shares Held
1.28BCall Options Held
13MPut Options Held
9.84M-
Vanguard Group Inc Valley Forge, PA171MShares$32.3 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$14.7 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.1 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.31 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $335B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...